{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:34:39Z","timestamp":1761975279599},"reference-count":26,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomarkers Med."],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.2217\/bmm.12.41","type":"journal-article","created":{"date-parts":[[2012,8,23]],"date-time":"2012-08-23T15:01:29Z","timestamp":1345734089000},"page":"401-407","source":"Crossref","is-referenced-by-count":22,"title":["Proficiency Testing Programs for Alzheimer\u2019s Disease Cerebrospinal Fluid Biomarkers"],"prefix":"10.1080","volume":"6","author":[{"given":"Niklas","family":"Mattsson","sequence":"first","affiliation":[{"name":"Clinical Neurochemistry Laboratory, Institute of Neuroscience &amp; Physiology, Department of Psychiatry &amp; Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, M\u00f6lndal,Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Andreasson","sequence":"additional","affiliation":[{"name":"Clinical Neurochemistry Laboratory, Institute of Neuroscience &amp; Physiology, Department of Psychiatry &amp; Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, M\u00f6lndal,Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria C","family":"Carrillo","sequence":"additional","affiliation":[{"name":"Department of Medical &amp; Scientific Relations, Alzheimer\u2018s Association, Chicago, IL,USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Staffan","family":"Persson","sequence":"additional","affiliation":[{"name":"Clinical Neurochemistry Laboratory, Institute of Neuroscience &amp; Physiology, Department of Psychiatry &amp; Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, M\u00f6lndal,Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leslie M","family":"Shaw","sequence":"additional","affiliation":[{"name":"Department of Pathology &amp; Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA,USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingrid","family":"Zegers","sequence":"additional","affiliation":[{"name":"European Commission, Joint Research Centre, Institute for Reference Materials &amp; Measurements (IRMM), Geel, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrik","family":"Zetterberg","sequence":"additional","affiliation":[{"name":"Clinical Neurochemistry Laboratory, Institute of Neuroscience &amp; Physiology, Department of Psychiatry &amp; Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, M\u00f6lndal,Sweden"},{"name":"UCL Institute of Neurology, London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaj","family":"Blennow","sequence":"additional","affiliation":[{"name":"Clinical Neurochemistry Laboratory, Institute of Neuroscience &amp; Physiology, Department of Psychiatry &amp; Neurochemistry, The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, M\u00f6lndal,Sweden"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2012,8,23]]},"reference":[{"key":"e_1_3_2_3_1_1","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2011.082"},{"key":"e_1_3_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.008"},{"key":"e_1_3_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70223-4"},{"key":"e_1_3_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.005"},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(03)00530-1"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.05.2243"},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2004.039347"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2006.081679"},{"key":"e_1_3_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70355-6"},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2011-101878"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1515\/CCLM.2010.131"},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2004.039735"},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.058776"},{"issue":"1","key":"e_1_3_2_3_14_1","first-page":"221","article-title":"Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid.","volume":"21","author":"Bjerke M","year":"2010","unstructured":"Bjerke M , PorteliusE, MinthonLet al. Confounding factors influencing amyloid Beta concentration in cerebrospinal fluid. Int. J. Alzheimers Dis. 21(1), 221\u2013228 (2010).","journal-title":"Int. J. Alzheimers Dis."},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.07.004"},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2010.4"},{"key":"e_1_3_2_3_17_1","doi-asserted-by":"publisher","DOI":"10.2217\/bmm.12.39"},{"key":"e_1_3_2_3_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/17.11.853"},{"key":"e_1_3_2_3_19_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2011.168641"},{"key":"e_1_3_2_3_20_1","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-2011-110212"},{"key":"e_1_3_2_3_21_1","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2005.063511"},{"key":"e_1_3_2_3_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/39.7.1530"},{"key":"e_1_3_2_3_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2006.07.009"},{"key":"e_1_3_2_3_24_1","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2009.008232"},{"key":"e_1_3_2_3_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-011-0808-0"},{"key":"e_1_3_2_4_2_1","unstructured":"The Alzheimer\u2018s Association QC program for CSF biomarkers. http:\/\/neurochem.gu.se\/thealzassqcprogram"}],"container-title":["Biomarkers in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/bmm.12.41","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:38:14Z","timestamp":1719124694000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/bmm.12.41"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["10.2217\/bmm.12.41"],"URL":"https:\/\/doi.org\/10.2217\/bmm.12.41","relation":{},"ISSN":["1752-0363","1752-0371"],"issn-type":[{"value":"1752-0363","type":"print"},{"value":"1752-0371","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8]]}}}